Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Long-Term Debt Repayments (2022 - 2025)

Core Laboratories (CLB) has 4 years of Long-Term Debt Repayments data on record, last reported at $20.0 million in Q3 2025.

  • For Q3 2025, Long-Term Debt Repayments fell 16.67% year-over-year to $20.0 million; the TTM value through Sep 2025 reached $67.0 million, down 24.72%, while the annual FY2024 figure was $82.0 million, 61.14% down from the prior year.
  • Long-Term Debt Repayments reached $20.0 million in Q3 2025 per CLB's latest filing, up from $12.0 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $85.0 million in Q2 2023 and bottomed at $12.0 million in Q2 2025.
  • Average Long-Term Debt Repayments over 4 years is $33.8 million, with a median of $20.0 million recorded in 2024.
  • Peak YoY movement for Long-Term Debt Repayments: skyrocketed 361.11% in 2023, then tumbled 75.29% in 2024.
  • A 4-year view of Long-Term Debt Repayments shows it stood at $82.0 million in 2022, then plummeted by 67.07% to $27.0 million in 2023, then fell by 25.93% to $20.0 million in 2024, then changed by 0.0% to $20.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Repayments were $20.0 million in Q3 2025, $12.0 million in Q2 2025, and $15.0 million in Q1 2025.